SCHEMBL4691232

SCHEMBL4691232

COc1cc2ncnc(Oc3ccc(Cl)cc3F)c2cc1O

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.62
KDR P35968 10/20 0.58
EGFR P00533 5/20 0.54
LCK P06239 1/20 0.54
FGFR1 P11362 2/20 0.51
FLT1 P17948 2/20 0.51
FLT4 P35916 2/20 0.51
EPHB2 P29323 1/20 0.51
BRAF P15056 2/20 0.48
RAF1 P04049 1/20 0.48
RET P07949 5/20 0.48
KIF5B P33176 5/20 0.48
MET P08581 1/20 0.48
RIPK2 O43353 1/20 0.46
NOD1 Q9Y239 1/20 0.46
FLT3 P36888 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4023047 0.95 TRPA1 (0.62) TRPA1KDREGFRLCKFGFR1
Trifluoroacetic Acid SCHEMBL4491696 0.87 TRPA1 (0.54) TRPA1KDREGFRLCKFGFR1
SCHEMBL14771225 0.86 TRPA1 (0.62) TRPA1KDREGFRLCKRET
SCHEMBL27482627 0.84 TRPA1 (0.51) TRPA1KDREGFRLCKFGFR1
SCHEMBL7214411 0.82 KDR (0.67) TRPA1KDREGFRLCKFGFR1
SCHEMBL2754217 0.82 TRPA1 (0.64) TRPA1KDREGFRBRAFRAF1
SCHEMBL14771448 0.81 TRPA1 (0.62) TRPA1KDREGFRLCKBRAF
SCHEMBL30000384 0.81 TRPA1 (0.62) TRPA1KDREGFRLCKBRAF
SCHEMBL4375838 0.81 TRPA1 (0.62) TRPA1KDREGFRLCKFLT1
SCHEMBL4491699 0.81 TRPA1 (0.59) TRPA1KDREGFRLCKFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296973-B1 GUANIDINE DERIVATIVES OF QUINAZOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2008-11-05 EP disclosed
US-7001904-B1 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases ASTRAZENECA AB (SE) 2006-02-21 US disclosed
EP-1296973-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES AstraZeneca AB (SE) 2003-04-02 EP disclosed
WO-2002000644-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2002-01-03 WO disclosed